Liu, Min
Bertolazzi, Giorgio
Sridhar, Shruti
Lee, Rui Xue
Jaynes, Patrick
Mulder, Kevin http://orcid.org/0000-0002-1568-6581
Syn, Nicholas http://orcid.org/0000-0002-6343-176X
Hoppe, Michal Marek http://orcid.org/0000-0002-0364-6080
Fan, Shuangyi
Peng, Yanfen http://orcid.org/0000-0003-1753-8547
Thng, Jocelyn
Chua, Reiya
Jayalakshmi,
Batumalai, Yogeshini
De Mel, Sanjay http://orcid.org/0000-0002-8881-3537
Poon, Limei
Chan, Esther Hian Li
Lee, Joanne
Hue, Susan Swee-Shan
Chang, Sheng-Tsung
Chuang, Shih-Sung
Chandy, K. George
Ye, Xiaofei http://orcid.org/0000-0002-7678-1152
Pan-Hammarström, Qiang http://orcid.org/0000-0003-1990-8804
Ginhoux, Florent http://orcid.org/0000-0002-2857-7755
Chee, Yen Lin
Ng, Siok-Bian http://orcid.org/0000-0001-6051-6410
Tripodo, Claudio http://orcid.org/0000-0002-0821-6231
Jeyasekharan, Anand D. http://orcid.org/0000-0001-9816-6137
Article History
Received: 26 April 2023
Accepted: 19 February 2024
First Online: 8 March 2024
Competing interests
: A.D.J. has received consultancy fees from DKSH/Beigene, Roche, Gilead, Turbine Ltd, AstraZeneca, Antengene, Janssen, MSD and IQVIA; and research funding from Janssen and AstraZeneca. The other co-authors have no conflicts of interest to declare.